back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-09-23 15:25 Tx date 2026-09-22 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Aharon, Gilad
4 - Director of Issuer
Holder: Rosalind Master Fund L.P. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$127,245
+249,500 vol $0.51 each |
4,649,500 | |
| Filed 2026-09-19 11:21 Tx date 2026-09-17 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Aharon, Gilad
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$100,000
+200,000 vol $0.50 each |
200,000 | |
| Filed 2026-09-19 11:14 Tx date 2026-06-15 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Aharon, Gilad
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-19 12:34 Tx date 2026-06-15 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Aharon, Gilad
4 - Director of Issuer
Holder: Rosalind Master Fund L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,400,000 | ||
| Filed 2026-08-19 12:25 Tx date 2026-06-15 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Aharon, Gilad
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
950,000 |